Partners Group in Talks to Buy Aroma-Zone Stake in Deal that Values Company at $2.3 Billion — 2nd Update
By Andrea Figueras
Partners Group is in exclusive talks to buy a majority stake in Aroma-Zone from Eurazeo in a potential deal that values all of the brand at about $2.3 billion, including debt, according to two people familiar with the transaction.
The companies said Thursday they entered exclusive talks about a majority stake in Aroma-Zone. In a press release, France's Eurazeo said it would retain a significant minority stake in Aroma-Zone, without specifying the size of the stake. The transaction would generate approximately 576 million euros of gross proceeds attributable to Eurazeo's balance sheet, it said.
The parties didn't disclose further financial details.
The deal would value all of Aroma-Zone at around 2 billion euros including debt, according to two people familiar with the transaction.
The Swiss private-equity group provided debt financing for Eurazeo's acquisition of Aroma-Zone in 2021, according to a Partners Group report. The potential transaction would be completed through Partners Group's direct private equity program, it said.
Aroma-Zone has tripled its revenue since 2021 and increased its number of stores, Partners Group said. The company sells beauty and wellness products such as facial serums, oils, masks and makeup.
Partners Group said it intends to support Aroma-Zone's executives to strengthen the brand's presence in new and existing markets and drive growth.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
August 06, 2026 06:54 ET (10:54 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States